The anti-biofilm wound dressing market size is estimated to be USD 758.41 million in 2022 and is expected to witness a CAGR of 9.87% during the forecast period 2023-2033. Surge in demand for cutting-edge wound care products and escalating number of surgical wounds are factors contributing to the market growth. Furthermore, increasing prevalence of non-communicable diseases and rising cases of chronic diseases are factors supporting the market growth. However, high cost of wound dressing is expected to hinder the growth.

Increasing prevalence of non-communicable diseases is expected to fuel the market growth during the forecast period as a result of factors including unhealthy sedentary lifestyles, antimicrobial resistance, and alcohol and smoking. For instance, the number of people with diabetes has climbed to an estimated 34.2 million, or approximately 10.5% of the population, according to the CDC’s National Diabetes Statistics report from 2020. In contrast, 7.3 million people with diabetes had not yet received a diagnosis, putting the number of persons with the disease at 26.8 million, according to a similar report.

Rising cases of chronic diseases is predicted to spur the market growth during the projected period. In the United States, 4 in 10 adults have two or more chronic diseases, and 6 in 10 adults have one or more chronic diseases, according to the U.S. CDC. Additionally, chronic diseases account for a significant portion of the nation’s USD 3.5 trillion annual healthcare costs and are the primary cause of disability and mortality. The prevalence of chronic diseases is increasing, which has led to an increase in surgeries. Increasingly, surgical site infections are being avoided by using wound dressing solutions including silver-based wound dressing.

Segmentation

By Mode of Mechanism

The market is categorized into biological, physical, chemical. In 2022, the chemical segment accounted for the highest revenue share due to the rising frequency of chronic wounds and the surge in number of surgeries performed around the world. The chemical-based anti-biofilm wound dressing materials enable multifaceted action against biofilm, speeding up the healing process and improving the effectiveness of the recovery process for chronic wounds. Additionally, it reduces the load of biofilm on both chronic and acute wounds, and risk of recontamination with microorganisms. Additional chemical subgroups include ionic silver, iodine, EDTA, and others. The chemical mode of mechanism sector is anticipated to exhibit the fastest CAGR over the projection period. The main factor driving segment expansion is the existence of numerous players supplying anti-biofilm wound dressing products with iodine and ionic silver. In order to better treat both acute and chronic wounds, researchers are also taking the initiative to market new anti-biofilm wound dressing treatments. For instance, the National Biofilms Innovation Centre of the UK announced in June 2020 that it had been awarded a grant of USD 28,949.03 to perform research and develop new product lines for controlling, engineering, and detecting biofilms.

By Application

The market is categorized into acute wounds and chronic wounds. In the global market, the chronic wounds segment accounted for the largest revenue share in 2022 owing to rising incidence of chronic diseases, particularly diabetes, around the world. Chronic or non-healing wounds develop when an injury doesn’t significantly heal for approximately 4 weeks. These kinds of wounds progress and either not heal at all or heal slowly than expected. Increasing infection and wound pain are two signs of chronic wounds. This can be caused by pressure on the incision or the area around it, exposure to infection or trauma, or a lack of blood and oxygen. According to estimates, 1% to 2% of people will experience a chronic wound at some point in their lives. It is estimated that 6.5 million Americans are affected by chronic wounds. Additionally, it is expected that as people age, the prevalence of chronic wounds would rise and impose a heavy financial burden on society. The acute wounds segment is predicted to have the fastest growth over the projection period due to the increasing cases of burns and trauma and rising number of operations performed worldwide. An acute wound is a rapid injury to the skin, such as an incision, an abrasion, a burn, a scratch, or a puncture wound. According to the typical wound healing procedure, it heals normally.

By End User

The market is segmented into home healthcare, hospitals, specialty clinics, and others. In 2022, the hospitals segment accounted for the largest revenue share owing to rise in surgical operations, and increase in burn, trauma, and sports-related injuries that demand for the use of wound care products to prevent surgical site infections. For instance, the Canadian Institute of Health (CIH) estimated that between 2019 and 2020, approximately 271,037 people were hospitalised as a result of sports-related injuries. Additionally, hospitals are regarded as significant purchasers of wound care and have long-term agreements with suppliers. The segment is therefore expected to grow during the forecast period as a result of the aforementioned factors. The home healthcare category is anticipated to experience the fastest CAGR during the projection period. Wound care products for home healthcare were more in demand during the pandemic outbreak. Patient benefits from these services include personal care, home-delivered meals, and more. This is anticipated to significantly influence the market. The U.S. Bureau of Labor Statistics projects that 13.0 million home healthcare and personal care assistants would be working in the country by the year 2020. Additionally, as older individuals are more inclined to use such services, the growing geriatric population around the world is anticipated to boost home healthcare services.Furthermore, the segment is anticipated to grow as the senior population rises.

Regional Markets

In 2022, North America region accounted for the highest revenue in the anti-biofilm wound dressing market and is expected to maintain its dominance during the forecast period. This is attributed to the rising rate of sports injuries, the increase in traffic accidents, and the existence of several key companies in the area. Additionally, a highly developed healthcare infrastructure and advantageous reimbursement policies are anticipated to fuel market expansion throughout the course of the projection period. The Asia Pacific anti-biofilm wound dressing market is predicted to expand at the fastest rate over the projected period. It is estimated that the presence of growing countries such as China, India, and Japan will accelerate market expansion in the Asia Pacific area. The demand for anti-biofilm wound dressing solutions in this region is also predicted to rise due to the region’s increasingly ageing population, and increase in the number of obese and diabetic patients. Also contributing to the rise in demand for anti-biofilm wound dressing solutions in this region is medical tourism. One of the key factors propelling the market expansion in Japan is the growing elderly population. More over one in four persons, according to Europa, are over 65.

Competitor Insights

Some of the key players operating in the anti-biofilm wound dressing market are B. Braun Melsungen AG, 3M, Mölnlycke Health Care AB, Lohmann & Rauscher, Imbed Biosciences, Smith & Nephew PLC, Coloplast, Urgo Medical, Next Science, and ConvaTec Inc.

To achieve a competitive edge, these companies are implementing a variety of growth strategies. Strategic partnerships, alliances, and agreements with different businesses and research institutions are seen to be the main strategies used by companies in this sector.

• For instance, the regenerative medicine products company Osiris Therapeutics, Inc., was acquired by Smith & Nephew PLC in April 2019. The company will broaden its client base and market reach by expanding its advanced wound management product portfolio with this purchase.

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including mode of mechanism, application, and end user from 2023 to 2033.

Report Scope:

Segmentation: Anti-biofilm Wound Dressing Market Report 2022 – 2033

Mode of Mechanism (Revenue, USD Million), 2022 – 2033

• Biological
  • Bacteriophage
  • Dispersin B
  • Lactoferrin
  • Others
• Physical
  • Ultrasound Debridement
  • Manual Debridement
  • Pulse Electrical Field
• Chemical
  • EDTA
  • Iodine
  • Ionic Silver
  • Others

Application (Revenue, USD Million), 2022 – 2033

• Acute Wounds
  • Burn Wounds
  • Surgical & Traumatic Wounds
• Chronic Wounds
  • Venous Leg Ulcers
  • Diabetic Foot Ulcers
  • Pressure Ulcers
  • Others

End user (Revenue, USD Million), 2022 – 2033

• Home Healthcare
• Hospitals
• Specialty Clinics
• Others

By Region (Revenue, USD Million), 2022 – 2033

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • Rest of MEA